Genome International

Genome International is a private, revenue-generating bioinformatics company offering a software-as-a-service platform for clinical genomic analysis. Its flagship product, Genome Explorer, provides rapid whole-genome analysis and clinical decision support for areas like cancer and inherited disorders, translating complex genomic data into actionable reports for clinicians. The company leverages proprietary algorithms, including the Shapiro-Senapathy (S&S) algorithm, to analyze 100% of the genome. With a leadership team featuring notable scientific advisors and a focus on the growing precision medicine market, Genome International positions itself as a key enabler for hospitals and researchers adopting genomic medicine.

Genome Explorer® platform featuring proprietary Shapiro-Senapathy (S&S) algorithm for splice site analysis and GenomeAI™ for whole-genome (coding & non-coding) clinical interpretation and decision support.

Competes in a crowded market with large players like Illumina (DRAGEN) and Sophia Genetics, as well as numerous specialized and academic software providers. Differentiation is based on whole-genome analysis capability and the proprietary S&S algorithm, but must continuously innovate to maintain an edge.